Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience

HPB (Oxford). 2012 Jun;14(6):382-9. doi: 10.1111/j.1477-2574.2012.00460.x. Epub 2012 Apr 9.

Abstract

Background: Spontaneous liver bleeding (SLB) is a rare but potentially fatal complication. In contrast to the East, various benign pathologies are the source of SLB in the West. An accurate diagnosis and a timely implementation of appropriate treatment are crucial in the management of these patients. The present study presents a large Western experience of SLB from a specialist liver centre.

Methods: A retrospective analysis of patients presented with SLB between January 1995 and January 2011.

Results: Sixty-seven patients had SLB, 44 (66%) were female and the median age at presentation was 47 years. Abrupt onset upper abdominal pain was the presenting symptom in 65 (97%) patients. The aetiology for SLB was hepatic adenoma in 27 (40%), hepatocellular carcinoma (HCC) in 17 (25%) and various other liver pathologies in the rest. Emergency treatment included a conservative approach in 42 (64%), DSA and embolization in 6 (9%), a laparotomy and packing in 6 (9%) and a liver resection in 11 (16%) patients. Eleven (16%) patients had further planned treatments. Seven (10%) died during the same admission but the mortality was highest in patients with HELLP syndrome. At a median follow-up of 54 months all patients with benign disease are alive. The 1-, 3- and 5-year survival of patients with HCC was 59%, 35% and 17%, respectively.

Conclusion: SLB is a life-threatening complication of various underlying conditions and may represent their first manifestation. The management should include initial haemostasis followed by appropriate staging investigations to provide a definitive treatment for each individual patient.

MeSH terms

  • Abdominal Pain / etiology
  • Adenoma, Liver Cell / complications
  • Adenoma, Liver Cell / therapy
  • Adult
  • Aged
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / therapy
  • Cysts / complications
  • Cysts / therapy
  • Embolization, Therapeutic
  • England
  • Female
  • HELLP Syndrome / therapy
  • Hemorrhage / diagnosis
  • Hemorrhage / etiology*
  • Hemorrhage / mortality
  • Hemorrhage / therapy*
  • Hemostatic Techniques
  • Hepatectomy
  • Hospital Mortality
  • Humans
  • Liver Diseases / diagnosis
  • Liver Diseases / etiology*
  • Liver Diseases / mortality
  • Liver Diseases / therapy*
  • Liver Neoplasms / complications
  • Liver Neoplasms / therapy
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Pregnancy
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • Young Adult